Ofi Invest Asset Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ofi Invest Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ofi Invest Asset Management from 13F filings

Historical chart of Ofi Invest Asset Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Ofi Invest Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Ofi Invest Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.0M 4.0M 2.25
2023-09-30 $3.7M 3.3k 1122.54

More positions owned by Ofi Invest Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Caterpillar (CAT)
salesforce (CRM)
Oracle Corporation (ORCL)
Eli Lilly & Co. (LLY)
BlackRock (BLK)
Pepsi (PEP)
UnitedHealth (UNH)

View all positions for Ofi Invest Asset Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
BlackRock
Braidwell
Lazard Asset Management
Davidson Kempner Capital Management
Readystate Asset Management
Citadel Advisors
Steelhead Partners
Bank of America Corporation
D. E. Shaw & Co
Tenor Capital Management
Bank Of Montreal
FMR
Nuveen Asset Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1